LEXARIA BIOSCIENCE CORP. Finance Lease, Liability, Noncurrent
LEXARIA BIOSCIENCE CORP. (LEXX) had Finance Lease, Liability, Noncurrent of $109.32 thousand as of 2024-08-31, per its 10-K filed 2024-11-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:FinanceLeaseLiabilityNoncurrent · last filed 2024-11-26
- 2024-08-31: Finance Lease, Liability, Noncurrent $109.32K.
- 2024-05-31: Finance Lease, Liability, Noncurrent $115.33K.
- 2024-02-29: Finance Lease, Liability, Noncurrent $122.49K.
- 2023-11-30: Finance Lease, Liability, Noncurrent $129.52K.
| Period end | Finance Lease, Liability, Noncurrent |
|---|---|
| 2024-08-31 | $109.32K 10-K · filed 2024-11-26 |
| 2024-05-31 | $115.33K 10-Q · filed 2024-07-12 |
| 2024-02-29 | $122.49K 10-Q · filed 2024-04-09 |
| 2023-11-30 | $129.52K 10-Q · filed 2024-01-12 |
| 2023-08-31 | $136.17K 10-K · filed 2024-11-26 |
| 2023-05-31 | $142.59K 10-Q · filed 2023-07-14 |
| 2023-02-28 | $0.00 10-Q · filed 2023-04-14 |
| 2022-11-30 | $0.00 10-Q/A · filed 2023-01-18 |
| 2022-08-31 | $7.40K 10-K · filed 2023-11-20 |
| 2021-08-31 | $49.99K 10-K · filed 2022-11-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |